01 May 2020
Visiongain has launched a new report Global Osteoporosis Pharmaceutical and Nutraceutical Market Report 2020-2030: Forecasts by Type of Pharmaceuticals viz. Antiresorptive (Bisphosphonates, Selective Estrogen Receptor Modulator, Rank Ligand Inhibitors, Parathyroid Hormone and Others), Anabolic and Others, by Type of Nutraceutical (Minerals, Herbs and Phytochemicals, Dairy Products and Others), and Profiles of Leading Companies and Regional and Leading National Market Analysis.
Global Osteoporosis Pharmaceutical and Nutraceutical Market – Our new study is an insight to the trends, opportunities and predicted revenues
With osteoporosis being a major concern among the aging population around the world, treatment and management of osteoporosis is a major area of development. Visiongain’s new report highlights the potential market scenario for 2020-2030 with the current trends, opportunities, business prospects, potential revenues and the leading companies in the global scenario.
Stay ahead in the game
Our 338-page report that includes 160 tables and 134 figures throws light on the pharmaceutical and nutraceutical market, the current market trends, new product launches, market estimates of the major therapeutic drug like antiresorptive, anabolic and Others along with nutraceuticals with its different types in both global and regional markets. The report also analyses about 35 different nutraceuticals that are widely used for the management of osteoporosis.
To access the data contained in this document please email firstname.lastname@example.org
Forecast from 2020-2030 and other analyses reveal the commercial prospects
In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares. We also provide original analyses with business outlooks and developments, qualitative analyses, company profiles, product profiles and commercial developments. A look into the impact of the recent COIVD-19 pandemic is also highlighted in the segments both in global and regional perspective.
Discover Sales Prediction for the global market and sub-markets
With the Global market estimations, the report also provides qualitative information on the various segments and subsegments:
• Antiresorptive: Bisphosphonate, SERM, Rank Ligand Receptor, Parathyroid Hormone, Others
• Herbs and Phytochemicals
• Dairy Products
Some Nutraceuticals Covered in the report
• Coronarin D
• Gambogic Acid
• L- Citrulline
• Muira Puama
• Oleanolic Acid
• Vitamin D/Vitamin D3
• Y- Tocoterinol
• Vitamin K
• Theaflavin 3
What are the prospects in the leading regions and countries?
The report covers the following regional markets with a detail analysis of its sub segments:
• Europe: UK, Germany, Italy, France, Spain
• Rest of the World
Our report shows that the USA holds the biggest market share in 2020, however India and China are expected to grow significantly by 2030. The report also discusses the regulatory framework for the osteoporosis pharma and nutra products in each of the country/region.
Companies Covered in the report
The report has covered in details the general profile, financial performance, current activities, acquisitions, collaborations and other details of the company’s profile depending on the organization.
• Eli Lilly
• Merck and Co.
• Sanofi Aventis
• Radius Health
• Kemin Europa
• Herbalife Nutrition
• Pharma Nord
Qualitative Analysis in the Report
The report covers the following analysis for the global pharmaceutical and nutraceutical market.
• SWOT analysis to understand the strength, Weakness, Opportunity and Threat of the market
• PEST analysis to understand the Political, Economic, Social and Technological factors influencing the market
Key Questions answered in the report
• How is the pharmaceutical and nutraceutical market evolving?
• What are the factors driving and restraining the growth of the market?
• A detail analysis of the market revenue from global and regional perspective.
• A detail analysis of the segments and sub-segments of the market and how the market is expected to evolve in the period 2020-2030.
• Factors influencing the growth of certain segments and sub segments
• The Impact of Covid-19 pandemic on the market
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Global liposomal drug delivery devices market is projected to grow at a CAGR of 10.69% by 2032.
21 June 2022
The global nanotechnology in drug delivery market was valued at US$53.0 billion in 2021 and is projected to grow at a CAGR of 18.7% during the forecast period 2022-2032.
20 June 2022
The global respiratory drug delivery technologies market was valued at US$59.51 billion in 2022 and is projected to grow at a CAGR of 7.31% during the forecast period 2022-2032.
15 June 2022
The global artificial intelligence (AI) in drug discovery market was valued at US$791 million in 2021 and is projected to grow at a CAGR of 30.7% during the forecast period 2022-2032.